Rationally re-designed mutation of NAD-independent l-lactate dehydrogenase: high optical resolution of racemic mandelic acid by the engineered Escherichia coli
© Jiang et al.; licensee BioMed Central Ltd. 2012
Received: 18 June 2012
Accepted: 4 October 2012
Published: 23 November 2012
NAD-independent l-lactate dehydrogenase (l-iLDH) from Pseudomonas stutzeri SDM can potentially be used for the kinetic resolution of small aliphatic 2-hydroxycarboxylic acids. However, this enzyme showed rather low activity towards aromatic 2-hydroxycarboxylic acids.
Val-108 of l-iLDH was changed to Ala by rationally site-directed mutagenesis. The l-iLDH mutant exhibited much higher activity than wide-type l-iLDH towards l-mandelate, an aromatic 2-hydroxycarboxylic acid. Using the engineered Escherichia coli expressing the mutant l-iLDH as a biocatalyst, 40 g·L-1 of dl-mandelic acid was converted to 20.1 g·L-1 of d-mandelic acid (enantiomeric purity higher than 99.5%) and 19.3 g·L-1 of benzoylformic acid.
A new biocatalyst with high catalytic efficiency toward an unnatural substrate was constructed by rationally re-design mutagenesis. Two building block intermediates (optically pure d-mandelic acid and benzoylformic acid) were efficiently produced by the one-pot biotransformation system.
KeywordsNAD-independent l-lactate dehydrogenase Site-directed mutagenesis Optical resolution d-mandelic acid
d-Mandelic acid, an aromatic 2-hydroxycarboxylic acid, is a valuable chiral building block for the synthesis of various pharmaceuticals, such as anti-obesity agents, antitumor agents, penicillins, and semisynthetic cephalosporins [1–3]. Chemical processes for mandelic acid production result in the racemic mixture of both stereospecific forms. Several biocatalytic methods, including lipase catalyzed enantioselective esterification , oxidoreductase catalyzed enantioselective oxidation, and microbial mediated enantioselective degradation [5–10], have been developed to prepare d-mandelic acid from racemic mandelic acid. Among these routes, oxidative resolution of racemic mandelic acid is much more promising because of its easy manipulation, exclusion of co-substrate addition, and high yield.
In recent years, rational re-design mutagenesis has emerged as a practical technique for the construction of biocatalysts with high catalytic efficiencies toward unnatural substrates, like the re-design of phenylalanine dehydrogenase [15–19], NAD-dependent l-lactate dehydrogenase , and d-amino-acid oxidase . In this study, l-iLDH from P. stutzeri SDM was rationally re-designed on the basis of the sequence alignment and active site structure of its homologous enzyme flavocytochrome b2. The mutant enzyme was expressed in E. coli, purified, and characterized. l-Mandelate dehydrogenation activity of the mutant enzyme was successfully enhanced. Whole cells of E. coli expressing the mutant l-iLDH were then used to perform the kinetic resolution of racemic mandelic acid.
Results and discussion
Rationally re-designed mutation
l-iLDH is a member of the l-α-hydroxyacid-oxidizing flavoprotein family, and is therefore related both structurally and by sequence to a number of other enzymes, including flavocytochrome b2 from Saccharomyces cerevisiae. The X-ray crystal structure of flavocytochrome b2 has been resolved (PDB ID code 1FCB), and the active site for 2-α-hydroxyacid dehydrogenation has been identified . Six amino acids which interact directly to the substrate have been pinpointed in the crystal structure , in which four amino acids are highly conserved in this protein family. However, the other two residues, Ala-198 and Leu-230 in flavocytochrome b2, which interact with the alkyl group of substrates, are not well conserved (Additional file 1 Figure S1). They are considered important for the substrate specificity of the enzyme . A s an aromatic 2-hydroxycarboxylic acid, l-mandelic acid is similar in structure with l-lactic acid except that phenyl group replaces alkyl group (Figure 1). Double mutation of the Ala-198 and Leu-230 to amino acids with smaller side chains (Gly and Ala, respectively) increased the ability of flavocytochrome b2 to utilize l-mandelate as a substrate . The altered substrate specificity may result from enlargement of the active site space to accommodate the phenyl group .
Kinetics of V108A l-iLDH
V108A l-iLDH was expressed in E. coli C43 (DE3), and it was purified using the protocol reported for the wild-type l-iLDH . The activity of wild-type l-iLDH for l-mandelate was below the detection limit for a reliable measurement with 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) as the electron acceptor . However, when the reaction time was extended, the oxidation product benzoylformate could be detected by HPLC, suggesting weak activity of l-iLDH for l-mandelate. The more sensitive electron acceptor 2,6-dichloroindophenol (DCIP) was used to determine the accurate kinetic parameters of the enzyme.
Kinetics of wild-type (WT) and V108A l -iLDH
445 ± 44
0.18 ± 0.01
185 ± 36
0.8 ± 0.1
8.3 ± 1.3
6.8 ± 1.0
97 ± 13
1.6 ± 0.1
Feasibility in co-production of d-mandelic acid and benzoylformic acid
Optimization of biocatalysis conditions
To increase the efficiency of whole-cell biocatalysis in the kinetic resolution of dl-mandelic acid, the bioconversion conditions were optimized. Benzoylformic acid could be degraded by microbial cells as other 2-keto-acids (Figure 3B and Additional file 6 Figure S6). The degradation decreased the bioconversion ratio and produced some by-products. EDTA was added at a concentration of 20 mM in the reaction system, which removed bivalent ions necessary for 2-keto-acid decarboxylase-catalyzed reactions  and then prevents the degradation of benzoylformic acid (Additional file 6 Figure S6).
Effect of dl -mandelic acid concentration on the biotransformation
dl-Mandelic acid concentration (g·L-1)
Reaction time (h)
Benzoylformic acid concentration (g·L-1)
Biotransformation efficiency (g·L-1·h-1)
Residual l-mandelic acid (g·L-1)
Residual d-mandelic acid (g·L-1)
Enantiomeric excess (%)
In this work, l-iLDH was rationally re-designed on the basis of sequence alignment and the active site structure of a homologous enzyme; a new biocatalyst with high catalytic efficiency toward an unnatural substrate was successfully constructed. A one-pot biotransformation system producing 2 building block intermediates was established using the biocatalyst. Under optimal conditions, a concentration of 20.1 g·L-1 of d-mandelic acid with high enantiomeric excess (> 99.5%) and 19.3 g·L-1 of benzoylformic acid was obtained from 40 g·L-1 of dl-mandelic acid.
Materials and methods
Enzymes and chemicals
Restriction enzymes were purchased from TaKaRa Bio Inc (China). FastPfu DNA polymerase and T4 DNA ligase were purchased from Transgen Biotech (China) and MBI (USA), respectively. d-mandelic acid, l-mandelic acid, racemic mandelic acid, benzoylformic acid, and 2,6-dichloroindophenol (DCIP) were all purchased from Sigma-Aldrich (USA). Isopropyl-β-D-1-thiogalactopyranoside (IPTG), dithiothreitol (DTT), and phenylmethanesulfonyl fluoride (PMSF) were obtained from Merck (Germany). All other chemicals were of reagent grade.
Site-directed mutagenesis and enzyme expression
To construct the mutant enzyme with valine-108 changed to alanine (V108A l-iLDH), site-directed mutagenesis was performed using the MutanBEST Kit (TaKaRa). The lldD gene coding for the wild-type l-iLDH was subcloned into the pMDTM18-T vector (TaKaRa) to construct the pMDTM18-T-lldD vector. The mutation was introduced using the following primers: 5′TTCACCCTTTCCACCGCG TCGGTCT3′ and 5′GGGAATCCCTTTCTTGTCTGCCGC3′ to amplify the entire sequence of pMDTM18-T-lldD. The linear PCR products were then cyclized using the ligase from the MutanBEST Kit. The mutant lldD gene (confirmed by automated DNA sequencing) was subcloned into the Hind III and Xho I restriction sites of the pETDuet-1 expression vector with a T7 promoter. Plasmid purification, DNA manipulation, and transformation were performed by the standard methods described by Sambrook et al. . E. coli DH5α and C43 (DE3) were used for general cloning and expression procedures, respectively. Lysogenic broth (LB) medium was used for E. coli cultivations. Ampicillin was used at a concentration of 100 μg· mL-1.
The expression and purification procedure of wild-type l-iLDH from recombinant E. coli has been described previously . The same procedure was used to express and purify the V108A mutant of l-iLDH. The purified enzymes were concentrated by ultrafiltration, desalted with Sephadex G-25, and then stored in 100 mM sodium phosphate buffer (pH 8.0, containing 0.1% Triton X-100) at −20°C. The expressed and purified enzyme was confirmed by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE).
The activities of wild-type and mutant l-iLDH were determined at 30°C in 1 mL of 50 mM Tris–HCl, pH 7.5, 0.0625 mM DCIP, and the enzyme. Protein amounts of wild-type enzyme and V108A l-iLDH mutant used to assay the kinetic parameters towards l-lactate were 0.05 μg and 0.2 μg, repectively; 4.0 μg and 1.0 μg proteins of wild-type and V108A l-iLDH were used to assay the kinetic parameters towards l-mandelate, respectively. The reaction was started by the addition of l-lactate or l-mandelate, and the rates of DCIP reduction were determined by measuring the absorbance change at 600 nm . To study effects of temperature and pH on enzyme stability, the enzyme was incubated at different temperature for 0.5 h or at different pH for 2 h, and then assayed with 1.25 mM l-lactate as substrate. MTT was used at a concentration of 0.2 mM instead of 0.0625 mM DCIP as electron acceptor in the assay of pH stability, since the molar extinction coefficient of DCIP changes with different pH. The rate of MTT reduction was determined by measuring changes in absorbance at 578 nm . One unit of l-iLDH activity was defined as the amount reducing 1.0 μmol of electron acceptor per minute under the test conditions. Protein concentration was determined by the Lowry method with BSA as a standard .
Recombinant E. coli C43 (DE3) cells were grown at 37°C on a rotary shaker (180 rpm) in LB medium containing ampicillin (100 μg·mL-1) to an OD620 of 0.6. Expression of the recombinant gene was induced by adding 1 mM IPTG at the same temperature for 6 h. After induction, the cells were harvested by centrifugation at 6,000 × g for 10 min at 4°C and then washed twice with 0.85% NaCl. The whole cells resuspended in ddH2O were used as the biocatalyst for the kinetic resolution of dl-mandelic acid.
Optimization of biotransformation conditions
To optimize the biotransformation conditions, 20-mL samples of the reaction mixture in a 100-mL flask were used. Ethylenediaminetetraacetic acid (EDTA) was added to a concentration of 20 mM in the reaction system. The biocatalysts were prepared from 12.5 g (DCW) L-1 of E. coli C43 (DE3) expressing the V108A mutant l-iLDH for the optimization of pH and temperature. The pH was adjusted from 4.0 to 10.0. The temperatures ranges were from 16°C to 58°C. The activity of whole-cell biocatalyst was judged by the concentration of benzoylformic acid produced. The dl-mandelic acid concentrations were 10.0–50.0 g·L-1, and the biotransformation was performed at 42°C at pH 7.0 for 12–54 h with 25 g (DCW) L-1 of biocatalyst.
Accurate concentrations of mandelic acid and benzoylformic acid were analyzed by high-performance liquid chromatography (HPLC, Agilent 1100 series, USA) using an Aminex HPX-87H column (Bio-Rad, USA) and the eluent using 10 mM H2SO4 solution at a flow rate of 0.4 mL·min-1. Samples from reaction systems during biocatalysis were centrifuged at 140,000 × g for 5 min to remove cells, and the supernatant was filtered by 0.22 μm pore size membrane filter for HPLC analysis.
Stereoselective assays of d-mandelic acid and l-mandelic acid were performed by HPLC analysis using a chiral column (DAICEL CHIRALCEL OJ-RH, Japan) and a tunable UV detector at 205 nm. The mobile phase consisted of 90% H2O (with 0.1% acetic acid added) and 10% acetonitrile (v/v) pumped at 0.4 mL·min-1 (15°C). Samples were prepared by the same procedure as using Aminex HPX-87H column. The optical purity of d-mandelate was expressed as enantiomeric excess (ee value), which was defined as the ratio of .
The work was supported by National Natural Science Foundation of China (31170052) and Chinese National Program for High Technology Research and Development (2011AA02A207).
The authors thank Professor Jan-Willem de Gier for providing E. coli C43 (DE3) for protein expression.
- Yamamoto K, Oishi K, Fujimatsu I, Komatsu K: Production of r-(−)-mandelic acid from mandelonitrile by Alcaligenes faecalis ATCC 8750. Appl Environ Microbiol. 1991, 57: 3028-3032.Google Scholar
- Kaul P, Banerjee A, Mayilraj S, Banerjee UC: Screening for enantioselective nitrilases: kinetic resolution of racemic mandelonitrile to (r)-(−)-mandelic acid by new bacterial isolates. Tetrahedron-Asymmetry. 2004, 15: 207-211. 10.1016/j.tetasy.2003.10.041.View ArticleGoogle Scholar
- He Y, Xu J, Xu Y, Ouyang L, Pan J: Biocatalytic synthesis of (r)-(−)-mandelic acid from racemic mandelonitrile by a newly isolated nitrilase-producer Alcaligenes sp. ECU0401. Chin Chem Lett. 2007, 18: 677-680. 10.1016/j.cclet.2007.04.034. 10.1016/j.cclet.2007.04.034View ArticleGoogle Scholar
- Choi WJ, Lee KY, Kang SH, Lee SB: Biocatalytic enantioconvergent separation of racemic mandelic acid. Sep Purif Technol. 2007, 53: 178-182. 10.1016/j.seppur.2006.06.024. 10.1016/j.seppur.2006.06.024View ArticleGoogle Scholar
- Kim BY, Hwang KC, Song HS, Chung N, Bang WG: Optical resolution of rs-(+/−)-mandelic acid by Pseudomonas sp. Biotechnol Lett. 2000, 22: 1871-1875. 10.1023/A:1005649908991. 10.1023/A:1005649908991View ArticleGoogle Scholar
- Takahashi E, Nakamichi K, Furui M, Mori T: r-(−)-mandelic acid production from racemic mandelic acids by Pseudomonas polycolor with asymmetric degrading activity. J Ferment Bioeng. 1995, 79: 439-442. 10.1016/0922-338X(95)91258-7.View ArticleGoogle Scholar
- Takahashi E, Nakamichi K, Furui M: r-(−)-mandelic acid production from racemic mandelic acids using Pseudomonas polycolor IFO 3918 and Micrococcus freudenreichii FERM-P 13221. J Ferment Bioeng. 1995, 80: 247-250. 10.1016/0922-338X(95)90824-J.View ArticleGoogle Scholar
- Miyamoto K, Ohta H: Enantioselective oxidation of mandelic acid using a phenylmalonate metabolizing pathway of a soil bacterium Alcaligenes bronchisepticus KU 1201. Biotechnol Lett. 1992, 14: 363-366. 10.1007/BF01021248.View ArticleGoogle Scholar
- He Y, Xu J, Pan J, Ouyang L, Xu Y: Preparation of (r)-(−)-mandelic acid and its derivatives from racemates by enantioselective degradation with a newly isolated bacterial strain Alcaligenes sp. ECU0401. Bioprocess Biosyst Eng. 2008, 31: 445-451. 10.1007/s00449-007-0181-5View ArticleGoogle Scholar
- Tsuchiya S, Miyamoto K, Ohta H: Highly efficient conversion of (±)-mandelic acid to its (r)-(−)-enantiomer by combination of enzyme-mediated oxidation and reduction. Biotechnol Lett. 1992, 14: 1137-1142. 10.1007/BF01027017.View ArticleGoogle Scholar
- Gao C, Ma C, Xu P: Biotechnological routes based on lactic acid production from biomass. Biotechnol Adv. 2011, 29: 930-939. 10.1016/j.biotechadv.2011.07.022View ArticleGoogle Scholar
- Gao C, Jiang T, Dou P, Ma C, Li L, Kong J, Xu P: NAD-Independent l-lactate dehydrogenase is required for l-lactate utilization in Pseudomonas stutzeri SDM. PLoS One. 2012, 7: e36519-, 10.1371/journal.pone.0036519View ArticleGoogle Scholar
- Gao C, Qiu J, Li J, Ma C, Tang H, Xu P: Enantioselective oxidation of racemic lactic acid to d-lactic acid and pyruvic acid by Pseudomonas stutzeri SDM. Bioresour Technol. 2009, 100: 1878-1880. 10.1016/j.biortech.2008.09.053View ArticleGoogle Scholar
- Gao C, Zhang W, Ma C, Liu P, Xu P: Kinetic resolution of 2-hydroxybutanoate racemic mixtures by NAD-independent l-lactate dehydrogenase. Bioresour Technol. 2011, 102: 4595-4599. 10.1016/j.biortech.2011.01.003View ArticleGoogle Scholar
- Seah SY, Britton KL, Baker PJ, Rice DW, Asano Y, Engel PC: Alteration in relative activities of phenylalanine dehydrogenase towards different substrates by site-directed mutagenesis. FEBS Lett. 1995, 370: 93-96. 10.1016/0014-5793(95)00804-IView ArticleGoogle Scholar
- Seah SY, Britton KL, Rice DW, Asano Y, Engel PC: Single amino acid substitution in bacillus sphaericus phenylalanine dehydrogenase dramatically increases its discrimination between phenylalanine and tyrosine substrates. Biochemistry. 2002, 41: 11390-11397. 10.1021/bi020196aView ArticleGoogle Scholar
- Paradisi F, Collins S, Maguire AR, Engel PC: Phenylalanine dehydrogenase mutants: efficient biocatalysts for synthesis of non-natural phenylalanine derivatives. J Biotechnol. 2007, 128: 408-411. 10.1016/j.jbiotec.2006.08.008View ArticleGoogle Scholar
- Paradisi F, Conway PA, Maguire AR, Engel PC: Engineered dehydrogenase biocatalysts for non-natural amino acids: efficient isolation of the d-enantiomer from racemic mixtures. Org Biomol Chem. 2008, 6: 3611-3615. 10.1039/b809147aView ArticleGoogle Scholar
- Chen S, Engel PC: Efficient screening for new amino acid dehydrogenase activity: directed evolution of Bacillus sphaericus phenylalanine dehydrogenase towards activity with an unsaturated non-natural amino acid. J Biotechnol. 2009, 142: 127-134. 10.1016/j.jbiotec.2009.03.005View ArticleGoogle Scholar
- Wilks HM, Halsall DJ, Atkinson T, Chia WN, Clarke AR, Holbrook JJ: Designs for a broad substrate specificity keto acid dehydrogenase. Biochemistry. 1990, 29: 8587-8591. 10.1021/bi00489a013View ArticleGoogle Scholar
- Sacchi S, Lorenzi S, Molla G, Pilone MS, Rossetti C, Pollegioni L: Engineering the substrate specificity of d-amino-acid oxidase. J Biol Chem. 2002, 277: 27510-27516. 10.1074/jbc.M203946200View ArticleGoogle Scholar
- Black MT, White SA, Reid GA, Chapman SK: High-level expression of fully active yeast flavocytochrome b2 in Escherichia coli. Biochem J. 1989, 258: 255-259.View ArticleGoogle Scholar
- Xia ZX, Mathews FS: Molecular structure of flavocytochrome b2 at 2.4 Å resolution. J Mol Biol. 1990, 212: 837-863. 10.1016/0022-2836(90)90240-MView ArticleGoogle Scholar
- Daff S, Manson FD, Reid GA, Chapman SK: Strategic manipulation of the substrate specificity of Saccharomyces cerevisiae flavocytochrome b2. Biochem J. 1994, 301: 829-834.View ArticleGoogle Scholar
- Sinclair R, Reid GA, Chapman SK: Re-design of Saccharomyces cerevisiae flavocytochrome b2: introduction of l-mandelate dehydrogenase activity. Biochem J. 1998, 333: 117-120.View ArticleGoogle Scholar
- Thompson JD, Gibson TJ, Plewniak F, Jeanmougin F, Higgins DG: The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res. 1997, 25: 4876-4882. 10.1093/nar/25.24.4876View ArticleGoogle Scholar
- Gouet P, Courcelle E, Stuart DI, Metoz F: ESPript: analysis of multiple sequence alignments in PostScript. Bioinformatics. 1999, 15: 305-308. 10.1093/bioinformatics/15.4.305View ArticleGoogle Scholar
- Ma C, Xu P, Dou Y, Qu Y: Highly efficient conversion of lactate to pyruvate using whole cells of Acinetobacter sp. Biotechnol Prog. 2003, 19: 1672-1676. 10.1021/bp0341242View ArticleGoogle Scholar
- Xue Y, Xu S, Liu Z, Zheng Y, Shen Y: Enantioselective biocatalytic hydrolysis of (r, s)-mandelonitrile for production of (r)-(−)-mandelic acid by a newly isolated mutant strain. J Ind Microbiol Biotechnol. 2011, 38: 337-345. 10.1007/s10295-010-0778-6View ArticleGoogle Scholar
- Rey P, Rossi JC, Taillades J, Gros G, Nore O: Hydrolysis of nitriles using an immobilized nitrilase: applications to the synthesis of methionine hydroxy analogue derivatives. J Agric Food Chem. 2004, 52: 8155-8162. 10.1021/jf048827qView ArticleGoogle Scholar
- Yadav GD, Sivakumar P: Enzyme-catalysed optical resolution of mandelic acid via rs(−/+)-methyl mandelate in non-aqueous media. Biochem Eng J. 2004, 19: 101-107. 10.1016/j.bej.2003.12.004.View ArticleGoogle Scholar
- Sambrook J, Fritsch EF, Maniatis T: Molecular Cloning: A Laboratory Manual. 1989, Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 2 Cold Spring Harbor, NYGoogle Scholar
- Janssen AJ, Trijbels FJ, Sengers RC, Smeitink JA, van den Heuvel LP, Wintjes LT, Stoltenborg-Hogenkamp BJ, Rodenburg RJ: Spectrophotometric assay for complex I of the respiratory chain in tissue samples and cultured fibroblasts. Clin Chem. 2007, 53: 729-734. 10.1373/clinchem.2006.078873View ArticleGoogle Scholar
- Nagel M, Andreesen JR: Purification and characterization of the molybdoenzymes nicotinate dehydrogenase and 6-hydroxynicotinate dehydrogenase from Bacillus niacini. Arch Microbiol. 1990, 154: 605-613.View ArticleGoogle Scholar
- Markwell MA, Haas SM, Bieber LL, Tolbert NE: A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal Biochem. 1978, 87: 206-210. 10.1016/0003-2697(78)90586-9View ArticleGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.